Data from randomized controlled trials on the effects of screening colonoscopies on colorectal cancer (CRC) incidence and mortality are not available. Observational studies have suggested that colonoscopies strongly reduce the risk of CRC, but there is little specific evidence on the effects of screening colonoscopies. METHODS: We performed a population-based case-control study of 3148 patients with a first diagnosis of CRC (cases) and 3274 subjects without CRC (controls) from the Rhine-Neckar region of Germany from 2003 to 2010. Detailed information on previous colonoscopy and potential confounding factors was collected by standardized personal interviews. Self-reported information on colonoscopies and their indications was validated by medical records. We used multiple logistic regression to assess the association between colonoscopy conducted for specific indications within the past 10 years and risk of CRC. RESULTS: A history of colonoscopy was associated with a reduced subsequent risk of CRC, independently of the indication for the examination. However, somewhat stronger associations were found for examinations with screening indications (adjusted odds ratio [OR] 0.09, 95% confidence interval [CI] 0.07-0.13) than for examinations with diagnostic indications, such as positive fecal occult blood test result (OR, 0.33; 95% CI, 0.19-0.57), surveillance after a preceding colonoscopy (OR, 0.33; 95% CI, 0.24-0.45), rectal bleeding (OR, 0.28; 95% CI, 0.20-0.40), abdominal symptoms (OR, 0.15; 95% CI, 0.10-0.21), or other (OR, 0.21; 95% CI, 0.14-0.30). Colonoscopy was also associated with a reduced risk of cancer in the right colon, regardless of the indication, although to a smaller extent than for other areas of the colon (OR for screening colonoscopy, 0.22; 95% CI, 0.14-0.33). CONCLU-SIONS: In a population-based case-control study, the risk of CRC was strongly reduced up to 10 years after colonoscopy for any indication. Risk was particularly low after screening colonoscopy, even for cancer in the right colon.
F lexible sigmoidoscopy (FS) and colonoscopy with detection and removal of adenomas offer great potential for prevention of colorectal cancer (CRC). Evidence from randomized controlled trials (RCTs) is restricted to studies on screening FS so far. [1] [2] [3] [4] Observational studies have addressed reduction of CRC risk after both FS and colonoscopy. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] However, in most studies of colonoscopy, including a previous report from our group, 19 no distinction was made between different indications of endoscopy. However, such a distinction would be of major interest for several reasons. First, risk reduction after screening colonoscopy is the parameter of primary interest for judgment of screening efficacy. Second, surveillance or diagnostic colonoscopies are typically conducted among people at increased risk for CRC, including those presenting after previous polypectomy or positive fecal occult blood test (FOBT) result, or people with symptoms possibly related to CRC. Possible risk reduction after surveillance or diagnostic colonoscopy might therefore be confounded by a priori increased CRC risk. Third, surveillance or diagnostic colonoscopies may lead to substantial contamination in RCTs on the efficacy of FS or colonoscopy. For example, in a recently reported RCT from the United States, almost half (46.5%) of participants in the control group underwent FS or colonoscopy for any reason during the 5-year screening phase and half underwent FS or colonoscopy after the screening phase. 4 It would therefore be of major interest to know how strongly endoscopy for other reasons, in particular surveillance or diagnostic colonoscopy, may reduce the risk of CRC and how this might affect estimates of risk reduction by screening colonoscopy.
We aimed to investigate specific associations of CRC risk with previous colonoscopy conducted for various indications, including primary screening, surveillance after a preceding colonoscopy, follow-up of positive FOBT result, or specific symptoms. Thorough distinction of multiple indications for previous colonoscopy was enabled by a substantial increase in numbers of cases and controls through ongoing recruitment and additional workup of data in our large population-based case-control study from Germany. 19 
Subjects and Methods

Study Design and Study Population
Our analysis is based on data from the DACHS (Darmkrebs: Chancen der Verhütung durch Screening) study, a populationbased case-control study conducted in the Rhine-Neckar area of Germany since 2003. In Germany, guaiac-based FOBT (samples from 3 consecutive days) and colonoscopy have been offered for primary screening in an opportunistic manner for a number of years. Between 1977 and 2002, annual screening by FOBT was offered for people aged 45 years or older. Since October 2002, annual screening by FOBT has been offered for people between 50 and 54 years of age. People aged 55 years or older have the following alternative screening offers: up to 2 screening colonoscopies 10 years apart or screening by FOBT every 2 years.
Details of the study design and data collection for the DACHS study have been reported previously. 19, 24 Briefly, patients with a first diagnosis of CRC (International Classification of Diseases, Tenth Revision [ICD-10] codes C18-C20) at age 30 years or older (no upper age limit) are being recruited at all of the 22 hospitals providing CRC surgery in the study region (approximately 2 million inhabitants). Controls are randomly selected from population registries using frequency matching by age, sex, and county of residence. They are informed about the study and invited to participate by mail and telephone. The study was approved by the ethics committees of the Medical Faculty of the University of Heidelberg and of the Medical Chambers of Baden-Württemberg and Rhineland-Palatinate. Written informed consent is obtained from each participant. Recruitment of participants is ongoing. Participants for the current analysis were selected from 3148 cases and 3274 controls recruited from 2003 to 2010. Based on hospital statistics, approximately 50% of eligible patients were recruited. The participation rate of eligible controls was 51%.
Data Collection
Personal interviews with cases and controls are conducted by trained interviewers using a standardized questionnaire. Interviews with cases are mostly conducted during a hospital stay, typically a few days after surgery. In addition, medical data are extracted from hospital charts. Interviews with controls are conducted at their homes. The interviews last for approximately 1 hour and address potential risk factors and preventive factors of CRC in great detail. In particular, detailed information is collected on previous large bowel endoscopies (among cases, "previous endoscopies" do not include those leading to the current diagnoses). Whenever such endoscopies are reported, we seek to validate the information by requesting all available endoscopy and histology reports from participants' physicians, from which data are extracted in a standardized manner. In a validation study, self-reports of previous endoscopies were found to be highly reliable; self-reported endoscopy (n ¼ 293) could be confirmed by medical records in 91% of cases. In addition, validation of self-reported absence of previous endoscopy was sought for a subsample of 84 participants and confirmed by physicians in each case. 25 Data extracted from the endoscopy and histology records include the following: type of endoscopy (colonoscopy, FS, rectoscopy), indication (predefined categories: screening; positive FOBT result; surveillance after preceding colonoscopy; rectal bleeding; abdominal symptoms, such as pain, diarrhea, or constipation; and other, including family history of CRC) completeness of colonoscopy (cecum reached) most advanced finding (advanced adenoma, other adenoma, no neoplasm); advanced adenomas were defined as 3þ adenomas, at least 1 adenoma 1 cm, or at least 1 adenoma with villous components or high-grade dysplasia.
Data were independently extracted by 2 trained medical documentation professionals, and any discrepancies were resolved by consensus after additional review.
Statistical Analysis
For statistical analysis, the following consecutive exclusions were made (reasons given in parentheses, and numbers shown in Figure 1 ): younger than 50 years of age (screening colonoscopy not generally recommended); history of inflammatory bowel disease (frequent surveillance colonoscopies due to increased risk of CRC); missing information on history of endoscopy, missing year of last endoscopy, or last endoscopy <1 year ago (to exclude endoscopies that might have been part of the current diagnostic process; additional sensitivity analyses were performed without this exclusion) or >10 years ago (recommended interval for screening colonoscopy) 26, 27 ; endoscopy report not obtained; last endoscopy was FS or rectoscopy rather than colonoscopy; and indication for colonoscopy was not included in the colonoscopy report. After these exclusions, 2516 cases and 2284 controls remained for the analysis.
We first described cases and controls according to age and sex and cases according to stage (using the Union for International Cancer Control [UICC] classification) and location (right colon, cecum to transverse colon; left colon, left flexure to sigmoid colon; rectum). Next, we assessed the frequency of previous colonoscopy, stratified by indication, according to sex, age, education, and family history. This analysis was performed among the controls to identify potential determinants of colonoscopy due to various indications in the base population. Differences between women and men, age groups (50-59, 60-69, 70-79, and 80þ years), educational groups (9 years, 10-11 years, 12þ years), and those with and without a history of CRC in a first-degree relative were tested for statistical significance by c 2 tests. Because the indication for colonoscopy was not always clear-cut and often more than one indication was given in the endoscopy reports, the following hierarchy (from high to low) was used for classification in the statistical analyses: surveillance, bleeding, abdominal symptoms, other specific reasons, positive FOBT result, and screening. In case of multiple indications, the indication with the highest hierarchy was selected. For example, if the report indicated that colonoscopy was performed for surveillance after a previous positive colonoscopy, the indication was always classified as surveillance, whether or not other indications were also listed. On the other hand, colonoscopies were classified as screening colonoscopies only if no other indications were listed. The rationale for this approach was to ensure that this group included true screening colonoscopies only and to avoid inclusion of apparent "screening colonoscopies" that had been performed for other reasons.
Finally, we assessed the risk of CRC according to history and indication of (only or last) colonoscopy within the past 1 to 10 years using subjects without previous endoscopy as the reference group. The time interval was individually determined for each case and control and refers to the time of diagnosis among cases and to the time of the interview among controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by multiple logistic regression, adjusting for the matching factors of age, sex, and county of residence to start and additionally for the following potential confounders [28] [29] [30] [31] : education (9, 10-11, 12þ years), history of CRC among a first-degree relative, smoking (never, current, former), body mass index, ever regular use (at least twice per week for 1 year) of nonsteroidal antiinflammatory drugs (NSAIDs), ever use of hormone replacement therapy (HRT), and ever participation in a general health screening examination, a potential indicator of general health behavior. In sensitivity analyses, we additionally controlled for calendar year (year of diagnosis for cases and year of recruitment for controls). Because allocation of effects to a single (the last) colonoscopy may be problematic in case of multiple colonoscopies, we performed further sensitivity analyses in which participants with multiple previous colonoscopies were excluded.
Apart from analyses of the total study population, stratumspecific analyses of the association between previous colonoscopy due to various indications and CRC risk were conducted for women, men, younger participants (<70 years), and older participants (70 years). Furthermore, specific risk estimates were derived by cancer stage (UICC I or II, III or IV) and location (right colon, left colon, rectum).
All statistical analyses were performed using SAS statistical software version 9.2 (SAS Institute Inc, Cary, NC). An a level of 0.05 was used for statistical tests.
Results
The main characteristics of the cases and controls are shown in Table 1 . Fifty-nine percent of the cases and controls were men, and the median age was 70 years in both groups. A family history of CRC and smoking were more common among cases than among controls, whereas controls more often had a higher level of education and had ever used aspirin, NSAIDs, or HRT regularly. The majority of cases were diagnosed in stage II or III, but all 4 stages were represented with several hundreds of cases. Approximately 2 of 5 cancers were located in the rectum, and the remaining cases were approximately equally distributed between the right and left colon.
Overall, 38.3% of controls had a previous colonoscopy ( Table 2 ). The most common indication was screening (12.0%), followed by abdominal symptoms (9.1%). Cancers spreading over more than one location (n ¼ 18, 0.7%) were allocated to the most proximal location.
Compared with women, men more often had a previous colonoscopy for screening or surveillance and less often had a previous colonoscopy due to abdominal symptoms. A previous colonoscopy, in particular a screening colonoscopy, had most commonly been conducted among controls between 60 and 79 years of age. Controls with a family history of CRC had a previous colonoscopy more often than those without such a history. This difference was seen for all indications but was most pronounced in the "other" category, which included 24 colonoscopies for which family history was explicitly stated as an indication. A history of colonoscopy was also considerably more common among never and former smokers than among current smokers and among women who ever used HRT regularly compared with women with no regular use of HRT. These differences were most pronounced for history of screening colonoscopy. No major variation in frequency and indication of previous colonoscopy was seen based on level of education or ever regular use of aspirin or NSAIDs. Table 3 shows the distribution of indications for previous colonoscopies among cases and controls according to calendar period. Only 4 of 216 colonoscopies (1.9%) conducted until 2002 were performed for screening, whereas screening was the most common indication (33.7%) for colonoscopies conducted from 2003 on. Table 4 shows the association between previous colonoscopy due to various indications and risk of CRC. Cases underwent a colonoscopy for any of the 6 indications much less often than controls. The most striking difference (1.7% vs 12.0%) was observed for screening colonoscopy. Age-, sex-, and county-adjusted ORs (95% CIs) for the association with CRC in the total study population ranged from 0.10 (0.07-0.14) for screening colonoscopy to 0.38 (0.28-0.52) for surveillance colonoscopy. The association was somewhat strengthened for surveillance colonoscopy and remained essentially unchanged for all other indications after additional adjustment for multiple covariates. Additional control for calendar year in sensitivity analyses did not lead to any relevant change of the associations (data not shown). Of those with a previous colonoscopy, 42% reported having more than one colonoscopy during their lifetime. Apart from the lack of a reliable estimate for surveillance colonoscopy, similar results were obtained in sensitivity analyses excluding these participants (Supplementary Table 1 ). With the exception of colonoscopy due to a positive FOBT result, risk reduction after preceding colonoscopy was tentatively stronger for men than for women, but 95% CIs were overlapping and strong, statistically significant risk reductions with ORs of 0.45 were seen for all subgroups. Similar patterns of strong risk reduction for all types of colonoscopy were likewise seen for participants younger than and older than 70 years of age. Adjusted ORs after preceding screening colonoscopy were less than 0.15 in all subgroups.
Similar results were also obtained when cases were stratified according to early (I or II) or late (III or IV) stage (Table 5 ). In contrast, all risk reductions were substantially less pronounced (and partly not statistically significant) for cancer in the right colon compared with cancer in the left colon and rectum. Nevertheless, strong risk reduction was seen after screening colonoscopy for cancer at any site, with adjusted ORs (95% CIs) of 0.22 (0.14-0.33), 0.07 (0.03-0.14), and 0.04 (0.02-0.08) for cancers in the right colon, left colon, and rectum, respectively. Additional sensitivity analyses that did not exclude cases and controls who underwent a colonoscopy less than 1 year before yielded essentially the same results (data not shown separately).
Discussion
In this large population-based study, the risk of CRC was small up to 10 years after screening colonoscopy. Compared with people who never underwent colonoscopy, the risk of CRC was reduced by approximately 90% after controlling for confounding factors, and the risk was still reduced by almost 80% even for cancer in the right colon. A somewhat lower but still substantial risk reduction (by 67%-85% for total CRC and by 29%-78% for cancer in the right colon) was observed for those who underwent colonoscopy for other reasons.
Our results expand previous analyses from a smaller data set of the DACHS study, which included cases and controls recruited from 2003 to 2007 only and did not allowed for detailed risk analyses by indication of colonoscopy. 19 To our knowledge, only 2 case-control studies from Canada and the United States have previously provided separate estimates of CRC risk after diagnostic and screening colonoscopy. 15, 23 In agreement with our results, a reduced risk of CRC was observed after both types of colonoscopy, with a stronger risk reduction after screening colonoscopy. However, with ORs of 0.69 and 0.81, risk reduction was much less pronounced in the Canadian Study than in the US study and our study, and the CIs were rather wide and included both risk reduction by more than 50% as well as no risk reduction at all. Apart from chance, possible reasons for the less pronounced risk reduction in the Canadian study may have been inclusion of colonoscopies conducted >10 years ago. Furthermore, cases and controls were recruited in 1997 to 2000, and previous colonoscopies were conducted in the 1980s and 1990s. In our study, most of the screening colonoscopies were performed after introduction of the screening colonoscopy program in 2002.
Major efforts of quality assurance, 32 along with progress in colonoscopy technology, may have contributed to more effective prevention of CRC. Our estimates of strong risk reduction after screening colonoscopy are in line with recent estimates from Switzerland 21 and the United States 23 and a similarly strong reduction in the incidence and mortality of distal CRC after screening sigmoidoscopy previously reported by Newcomb et al. 5, 14 The lower risk of CRC after screening colonoscopy compared with colonoscopy conducted for other indications is unlikely to reflect differences in the quality or effects of colonoscopy. A more plausible explanation might by the inherently higher risk of those who undergo colonoscopy for surveillance, diagnostic workup of a positive FOBT result or symptoms, or other reasons, such as a positive family history.
However, much less pronounced estimates of CRC risk reduction have been reported in RCTs on FS from Europe and the United States. [1] [2] [3] [4] Apart from possible biases in observational studies such as ours (discussed in detail in the following text), there are several reasons that might explain most of this apparent discrepancy. First, FS does not provide protection against proximal CRC, and risk reduction for distal CRC was substantially stronger than risk reduction for total CRC. Second, the main results of RCTs pertain to "intention-to-screen" analyses, comparing the risk of CRC between those who were offered screening and those who were not. In contrast, our estimates refer to a comparison between those who actually underwent colonoscopy and those who did not. Even though several sigmoidoscopy trials also reported results of "per-protocol analyses" (adjusting for nonadherence as well as potential differences in characteristics of attenders and nonattenders) that showed much stronger effects than the intention-to-screen analyses, none of the trials adjusted for contamination (ie, use of gastrointestinal endoscopy outside the screening offer in the control group). The amount of contamination was reported in the FS RCT from the United States, where it was substantial; 46.5% of the controls underwent a sigmoidoscopy or colonoscopy during the screening phase, and 48% underwent a colonoscopy after the screening phase. We have recently shown that such high rates of contamination, along with the rates of nonadherence observed in the trials, lead to substantial underestimation of protection for those actually screened. 33 This underestimation may explain most of the apparent discrepancy between the RCT results and the effect estimates from observational studies (such as ours) that compare risks of those who actually underwent sigmoidoscopy/colonoscopy with those who did not.
Our study has specific strengths and limitations. The strengths include the population-based design and the large sample size, which allowed estimation of associations at high levels of precision. Furthermore, detailed information on indication and findings was available from colonoscopy reports. The limitations are mainly related to the observational study design. We cannot exclude potential selection bias, because only slightly more than 50% of eligible cases and controls were recruited. Although this proportion might appear low on first view, it is probably close to the maximum that is possible in a population-based study with interview-based data collection, no upper age limit, and a median age of participants of 70 years. The main limiting factor in complete recruitment of cases, which was performed in all of the 22 clinics in the study area providing CRC surgery, was work overload of physicians, which is unlikely to be related to history of colonoscopy. Other possible reasons for missed cases include surgery outside the study region (which again is unlikely to be related to history of colonoscopy) or no surgery at all (eg, due to diagnosis without tissue in patients near the end of life). However, the latter reason is likely to be rare. For example, in a recent cancer registry-based study from Germany, 98% of cases were microscopically confirmed using resected tissue. 34 Nevertheless, we cannot exclude the possibility of selection bias due to incomplete case enrollment.
Among controls, participation was lowest among women at the oldest ages. However, the results were rather consistent across sex and age groups with differential participation rates, which is a finding that does not support a major role of selection bias. Nevertheless, some overestimation of protection due to higher participation rates of controls with previous colonoscopy may have occurred.
Information on the main exposure variable, previous colonoscopy and its indication, was based on self-reports and colonoscopy records. Validation of self-reported endoscopy by medical records was successful in the vast majority of participants. We did not validate self-reported lack of previous endoscopy in all participants, because this information was confirmed in all 84 cases in our previous validation study. 25 Indication of colonoscopy was extracted from retrospectively collected colonoscopy reports, which varied in detail and quality, rather than by prospective application of standardized reporting forms. We therefore cannot exclude some misclassification of indication. Nevertheless, the observed temporal patterns (with screening colonoscopies being extremely rare before introduction of this offer in Germany) and distribution of findings (substantially higher prevalence of adenomas detected at colonoscopies conducted for surveillance or due to visible or occult rectal bleeding) support the plausibility of the reported indications.
Confounding by factors related to both previous colonoscopy and risk of CRC is another potential limitation. We carefully controlled for a number of such factors in multivariable analyses, which did not alter the risk estimates to a relevant extent. However, we cannot exclude residual confounding by additional factors, such as diet or physical activity, or less than perfect measurement of the factors controlled for.
For logistical reasons, it was not possible to confirm the absence of CRC (eg, by colonoscopy) among controls. However, according to data from the German national colonoscopy registry, less than 1% of older adults in Germany have a previously undetected CRC. 32 Therefore, the potential bias from this source should be very small. Nevertheless, strictly speaking, our results refer to risk of clinically manifest CRC (a potentially even more relevant outcome) rather than to risk of any CRC.
Despite its limitations, our study indicates that the risk of CRC, in particular distal CRC, is very low up to 10 years after screening colonoscopy, and this observation is consistent with the very low risk of distal CRC observed within 10 years after screening FS in recently published RCTs. [1] [2] [3] [4] In contrast to the latter, very low risk was also found for cancer in the right colon. Furthermore, a low risk of CRC was found up to 10 years after colonoscopies conducted for indications other than screening. In light of increasing use of diagnostic colonoscopy in many countries, 35, 36 these results underline the importance of taking contamination by diagnostic colonoscopies into account in the design and analysis of results from screening endoscopy RCTs.
